Trials / Recruiting
RecruitingNCT04808596
Pulmonary Hypertension Biorepository and Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
Detailed description
The aim of this project will be to establish a broad and wide-ranging registry and biorepository of blood samples from patients with pulmonary hypertension, including all WHO groups I-V to be used for future research in these areas. This will be both a retrospective and prospective project. The registry and biorepository will be utilized to study and grow our knowledge of the cellular mechanisms and mediators of the disease and, in turn, contribute to advancements in treatment.
Conditions
- Pulmonary Hypertension
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension Due to Left Heart Disease
- Pulmonary Hypertension, Primary
- Pulmonary Hypertension Due to Lung Diseases and Hypoxia
- Pulmonary Hypertension, Primary, 4
- Pulmonary Hypertension, Primary, 2
- Pulmonary Hypertension, Primary, 3
- Chronic Thromboembolic Pulmonary Hypertension
Timeline
- Start date
- 2020-08-10
- Primary completion
- 2026-12-31
- Completion
- 2027-07-31
- First posted
- 2021-03-22
- Last updated
- 2025-08-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04808596. Inclusion in this directory is not an endorsement.